MentiNova Raises $500,000 for Parkinson’s Treatments
MentiNova Inc., which is developing an oral medication to help treat symptoms of Parkinson’s disease, has raised $500,000 in new funding. Foundation Venture Capital Group, a New Jersey Health Foundation affiliate, provided the money, which will go toward research and development.
28 January 2013•3 mins read
